In BRCA2 mutation carriers the cumulative risk of male breast cancer at age 70 years has been estimated 6.8 % [42], but evidences for a correlation between the location of the mutation within BRCA2 gene and risk of male breast cancer are still lacking [43]. The gene discussed is BRCA2; the disease is breast carcinoma.